- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04646070
Superomedial Pedicle Versus Inferior Pedicle Techniques in Wise Pattern Reduction Mammaplasty :A Comparison Study
November 21, 2020 updated by: Rami Ali Abdelkareem Eleiba, Kafrelsheikh University
A comparison study between superomedial and Inferior pedicle techniques in wise pattern reduction mammaplasty
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
To compare complications of both techniques in wise pattern reduction mammaplasty and to correlate between complications and patient mediated factors
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kafr Ash Shaykh, Egypt
- Recruiting
- Kafr Elsheikh University Hospital
-
Contact:
- Rami Ali Abdelkareem Eleiba, Master
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
-
Exclusion Criteria:
- previous extensive breast surgery Breast cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Wise pattern reduction mammaplasty using Inferior pedicle
|
Breast reduction surgery
Other Names:
|
|
Active Comparator: Wise pattern reduction mammaplasty using superomedial pedicle
|
Breast reduction surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare complications of both techniques including nipple areola complex necrosis
Time Frame: 30 days postoperative
|
Complications include NAC necrosis and other minor complications including wound dehiscence and seroma or hematoma
|
30 days postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To correlate between complications and patient mediated factors
Time Frame: 30 days postoperative
|
Patient mediated factors including age, BMI, preoperative hb, suprasternal notch to nipple distance
|
30 days postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Safwat Adel hegazy, MD, Kafr elsheikh university
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2020
Primary Completion (Anticipated)
January 20, 2021
Study Completion (Anticipated)
January 20, 2021
Study Registration Dates
First Submitted
November 21, 2020
First Submitted That Met QC Criteria
November 21, 2020
First Posted (Actual)
November 27, 2020
Study Record Updates
Last Update Posted (Actual)
November 27, 2020
Last Update Submitted That Met QC Criteria
November 21, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- Reduction mammaplasty
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reduction mammaplasty
-
Federal University of São PauloUniversidade do Vale do SapucaiCompleted
-
University Hospital BratislavaComenius UniversityCompletedQuality of Life | Signs and Symptoms | MacromastiaSlovakia
-
Daniela Francescato VeigaUniversidade do Vale do SapucaiCompleted
-
Daniela Francescato VeigaUniversidade do Vale do SapucaiCompleted
-
Daniela Francescato VeigaCompleted
-
Daniela Francescato VeigaCompleted
-
Ohio State University Comprehensive Cancer CenterWithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in Situ
-
Institut Cancerologie de l'OuestActive, not recruiting
-
Institut Cancerologie de l'OuestCompletedBreast Cancer FemaleFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting